Stay updated on IGN002 Clinical Trial in Refractory NHL
Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.

Latest updates to the IGN002 Clinical Trial in Refractory NHL page
- Check2 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check23 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check52 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check66 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase 1 extension study for the IGN002 treatment for Non-Hodgkin Lymphoma, while adding information about the study's collaborators and a revision number update.SummaryDifference34%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL
Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.